SEI Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

SEI Investments’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.2M	Buy	26,218 +392	+2%	+$207K	0.01%	975
2026 Q2	$13.9M	Buy	25,826 +1,628	+7%	+$834K	0.01%	971
2026 Q1	$12.7M	Buy	24,198 +1,122	+5%	+$536K	0.01%	1007
2025 Q4	$13.4M	Buy	23,076 +3,961	+21%	+$2.02M	0.01%	916
2025 Q3	$8.77M	Buy	19,115 +1,573	+9%	+$587K	0.01%	1071
2025 Q2	$5.31M	Buy	17,542 +1,547	+10%	+$461K	0.01%	1248
2025 Q1	$5.3M	Buy	15,995 +7,766	+94%	+$2.55M	0.01%	1243
2024 Q4	$2.54M	Sell	8,229 -1,023	-11%	-$288K	﹤0.01%	1589
2024 Q3	$1.96M	Sell	9,252 -547	-6%	-$140K	﹤0.01%	1695
2024 Q2	$2.75M	Sell	9,799 -656	-6%	-$156K	﹤0.01%	1508
2024 Q1	$2.79M	Sell	10,455 -463	-4%	-$109K	﹤0.01%	1473
2023 Q4	$2.53M	Buy	10,918 +830	+8%	+$145K	﹤0.01%	1498
2023 Q3	$1.47M	Sell	10,088 -3,176	-24%	-$598K	﹤0.01%	1734
2023 Q2	$3.06M	Buy	13,264 +5,221	+65%	+$1.41M	0.01%	1443
2023 Q1	$1.95M	Buy	8,043 +2,779	+53%	+$757K	﹤0.01%	1638
2022 Q4	$1.53M	Buy	+5,264	New	+$515K	﹤0.01%	1606
2022 Q2	–	Sell	-2,823	Closed	-$277K	–	2690
2022 Q1	$277K	Buy	2,823 +80	+3%	+$6.74K	﹤0.01%	2334
2021 Q4	$232K	Sell	2,743 -234	-8%	-$19.2K	﹤0.01%	2425
2021 Q3	$238K	Hold	2,977	–	–	﹤0.01%	2394
2021 Q2	$290K	Buy	+2,977	New	+$352K	﹤0.01%	2325
2019 Q1	–	Sell	-465	Closed	-$100K	–	2948
2018 Q4	$100K	Hold	465	–	–	﹤0.01%	2200
2018 Q3	$100K	Sell	465 -5,291	-92%	-$1.33M	﹤0.01%	2081
2018 Q2	$1.61M	Buy	+5,756	New	+$1.01M	0.01%	1410

Other funds holding MDGL

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SEI Investments's MDGL Position: Q3 2026 in Review

SEI Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 1.5% in Q3 2026, buying an estimated $207K and bringing the position to 26,218 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #975.

SEI Investments first reported a position in MDGL in Q2 2018 and has held it in 23 quarters since. The position peaked at $13.9M in Q2 2026. 290 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

SEI Investments held 26,218 shares of Madrigal Pharmaceuticals worth $13.2M as of Q3 2026.
SEI Investments bought 392 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $207K.
Madrigal Pharmaceuticals made up 0.01% of SEI Investments's portfolio in Q3 2026, its #975 holding.
SEI Investments first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 23 quarters since.
SEI Investments's Madrigal Pharmaceuticals position peaked at $13.9M in Q2 2026.
290 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.